BRAF and neoplasm: Similar findings of PDPK1 promoting tumor initiation in cooperation with Erbb2 or Ras activation have been made in breast cancer cells40,41, or in BRAF V600 mutant melanoma where loss of PDPK1 reduced tumor formation42.